BioSistemika published an article by Head of Engineering Anže Videnič examining the challenges and gaps in laboratory software for regulated markets.
Public source
Publisher name
Public post
Is your laboratory software ready for regulated markets? It’s a question that often comes up when there is already a reason to act: a new customer, a new application, or…
Company
BioSistemika
High-quality digital solutions for laboratories
- Industry
- Biotechnology
- Location
- Ljubljana, SI
- Company size
- 11–50 employees
About BioSistemika
BioSistemika specializes in custom software development, digitalization consulting, and development of laboratory software products. Over the past 10 years, we have worked with many laboratory instrument manufacturers and delivered software products that were tailored to our customer needs. We have completed several in vitro diagnostic (IVD) projects and non-IVD software projects for our customers for which we developed entire software product suites, starting from requirements, design specification, coding, and testing. For IVD, we are working in accordance with ISO 13485 and IEC 62304. We have vast experience in software-hardware integrations and are supporting standardization efforts that enable interoperability. BioSistemika also has immense experience with resolving compatibility with laboratory equipment, other software systems, connections between coding languages, big data storage, and analysis. We aim to empower scientists with professional software that has an excellent user experience. Years of experience in customizing software solutions gained us trusted partners. We cooperate with leading Life Science companies such as Gilson, Agilent, Alifax, ADInstruments, 4titude, and many others. BioSistemika has also consulted the most prominent companies about setting up a digitalization strategy. We help to implement it and build all the missing links by integrating existing software solutions or building new ones. We have successfully collaborated in multiple grant-funded R&D projects as well as lead international consortia. We have an experienced project management team and back office at our disposal, capable of coordinating and managing complex R&D activities, administration as well as the subsequent commercialization stages.
See moreLatest activity
Latest activity from BioSistemika
3 signals
Presence & Recognition
BioSistemika Head of Software Engineering Anže Videnič will speak at the plenary stage of MSS Biotechevents in Bled on September 15, exploring why regulated science may be particularly well prepared for AI.
Presence & Recognition
BioSistemika was named one of the Future 760 Louveenia companies at the Future500 Forum held alongside the Strategic Forum in Bled.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Laboperator
Laboperator published an article examining how connected laboratories are changing healthcare and medical research and the future of laboratory automation.
Research & Knowledge
Culture Biosciences
Culture Biosciences published a new white paper highlighting the value of a connected software ecosystem for bioprocess development and how Console Software brings experimental design, execution, data, analytics, and AI together in one platform.
Research & Knowledge
Ardigen
Ardigen published a new article analyzing recent research on the transition from AI-generated answers to testable scientific workflows.
Research & Knowledge
Firefinch Software
Firefinch Software published its latest blog post titled GDocP, discussing the importance of audit trails, e-signatures, and ALCOA data integrity in developing a GMP-ready biotech instrument.
Research & Knowledge
Copia Scientific